Skip Navigation

Create free account

Meg Tirrell

Meg Tirrell

CNBC Senior Health & Science Reporter

Meg Tirrell is CNBC's senior health and science reporter.

Latest

Pfizer offers $43 billion to buy cancer drugmaker Seagen

Meg TirrellMarch 13, 2023

SVB fallout: The impacts on the biotech sector

Meg TirrellMarch 13, 2023

Lilly cuts insulin prices by 70%

Meg TirrellMarch 1, 2023

Asia-Pacific markets trade mixed after Nasdaq extends gains backed by technology

Jihye LeeJanuary 9, 2023

FDA clears Pfizer, Moderna Covid vaccines for young children

Meg TirrellJune 17, 2022

Moderna's new Covid booster provides superior protection against omicron

Meg TirrellJune 8, 2022

Gilead CEO Daniel O’Day breaks down new Trodelvy data in breast cancer patients

Meg TirrellJune 6, 2022

Pfizer to submit Covid vaccine data for kids under age 5 this week

Meg TirrellMay 23, 2022

FDA authorizes Pfizer Covid booster shots for kids 5-11

Meg TirrellMay 17, 2022

Moderna CEO Stephane Bancel on earnings: We expect second half of 2022 to be stronger

Meg TirrellMay 4, 2022

CNBC Pro

Watch CNBC's full interview with Moderna CEO Stephane Bancel on earnings

Meg TirrellMay 4, 2022

Biogen CEO Michel Vounatsos to step down following troubled Alzheimer's drug launch

Meg TirrellMay 3, 2022